Metabolic syndrome markers and risk of hyperglycemia in pregnancy: a cross-sectional cohort study

Joice M Vernini,Claudia G Magalhães,Roberto A Costa,Silvana A M Lima,Iracema M Calderon,Marilza V Rudge,José E Corrente,Mariana A Arantes,Bianca F Nicolosi

doi:10.1038/s41598-020-78099-3

Joice M Vernini, Claudia G Magalhães + Show 7 more

Open Access

https://doi.org/10.1038/s41598-020-78099-3

Copy DOI

Journal: Scientific Reports	Publication Date: Dec 1, 2020
Citations: 4	License type: open-access

Affiliation: Universidade Estadual Paulista (Unesp)

Abstract

The aim was to assess the role of Metabolic Syndrome (MetS) diagnostic markers, recommended by three different guidelines, in the prediction of hyperglycemia in pregnancy. This cross-sectional cohort study included 506 non-diabetic women, with a singleton pregnancy, who underwent a diagnostic test for hyperglycemia at 24–28 weeks. Clinical, anthropometric, and laboratory data were obtained. The relationship between MetS markers and the risk of hyperglycemia was evaluated by backward stepwise logistic regression analysis (OR, 95% CI). The limit of statistical significance was 95% (p < 0.05). Triglycerides (TG) ≥ 150 mg/dL, blood pressure (BP) ≥ 130/85 mmHg, fasting glucose (FG) ≥ 100 mg/dL, and waist circumference (WC) > 88 cm were identified as independent risk factors for hyperglycemia in pregnancy. These results might help the selective screening of hyperglycemia in pregnancy.

Highlights

The aim was to assess the role of Metabolic Syndrome (MetS) diagnostic markers, recommended by three different guidelines, in the prediction of hyperglycemia in pregnancy
According to 75 g-OGTT response, study participants were assigned to three groups: Non-diabetic (ND, normal 75 g-OGTT and Glucose Profile (GP)); Mild Gestational Hyperglycemia (MGH); and Gestational diabetes mellitus (GDM)
This study evaluated the role of MetS diagnostic markers recommended by different sets of g uidelines[2,3,4] in the prediction of MGH and GDM risk

Summary

Introduction

The aim was to assess the role of Metabolic Syndrome (MetS) diagnostic markers, recommended by three different guidelines, in the prediction of hyperglycemia in pregnancy. This cross-sectional cohort study included 506 non-diabetic women, with a singleton pregnancy, who underwent a diagnostic test for hyperglycemia at 24–28 weeks. Triglycerides (TG) ≥ 150 mg/dL, blood pressure (BP) ≥ 130/85 mmHg, fasting glucose (FG) ≥ 100 mg/dL, and waist circumference (WC) > 88 cm were identified as independent risk factors for hyperglycemia in pregnancy. These results might help the selective screening of hyperglycemia in pregnancy. The cost-effectiveness of this strategy, as well as its effects on short- or long-term maternal and offspring outcomes remain unknown and evidence supporting its use is still insufficient[17]

Objectives

Methods

Results

Conclusion